
Chiasma, Inc. CHMA
Chiasma, Inc. DPO 2011-2026 | CHMA
DPO Jährlich Chiasma, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 25.4 K | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 25.4 K | 25.4 K | 25.4 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 21.75 | 1.59 % | $ 1.02 B | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.91 | 1.61 % | $ 6.69 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
75.2 | $ 22.29 | 1.5 % | $ 3.69 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.1 | 0.37 % | $ 438 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 23.2 | -0.26 % | $ 2.95 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.42 | -1.39 % | $ 378 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
ContraFect Corporation
CFRX
|
1.83 K | - | -5.16 % | $ 5.39 M | ||
|
Cardiff Oncology
CRDF
|
406 | $ 1.72 | -0.29 % | $ 115 M | ||
|
BioXcel Therapeutics
BTAI
|
34.2 K | $ 1.07 | 0.94 % | $ 13.1 M | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 1.95 | 1.83 % | $ 405 M | ||
|
CASI Pharmaceuticals
CASI
|
123 | - | - | $ 35.4 M |